Actively Recruiting
Study of Pseudoephedrine to Prevent Ear Barotrauma During Hyperbaric Oxygen Therapy in Adults
Led by John Muir Health · Updated on 2025-08-27
90
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether taking pseudoephedrine can help prevent middle ear injury, called barotrauma, during hyperbaric oxygen therapy HBOT. Pseudoephedrine is a drug commonly used to relieve nasal or sinus pain and pressure. This study is designed to evaluate if pseudoephedrine reduces ear pain associated with HBOT compared to a placebo. Participants will receive a single oral dose of either 60 mg pseudoephedrine or a placebo pill between 45 and 120 minutes before undergoing HBOT. The study compares these two groups in a randomized, quadruple-blind design. There are no additional treatments or procedures beyond the pill intake and the HBOT session. During the study, participants ears will be examined before and after the HBOT session. They will also self-report any ear pain experienced during therapy. The main measurement is the change in ear pain during the 45-60 minute therapy session. Researchers will also monitor the incidence of successful compression one minute into the therapy. No further tests or follow-ups are planned after the therapy and ear exams.
CONDITIONS
Brief Title
Barotrauma in Hyperbaric Oxygen Therapy
Research Team
J
Jacinta Showers, RN
T
Todd Kessinger, MD, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here